Biotechnology Contract Manufacturing Market worth $24.8 billion | MarketsandMarkets - Ucommune International (NASDAQ:UK)

"In January 2023, WuXi Biologics entered into a licensing agreement with GSK plc for using WuXi Biologics' proprietary technology platforms. Under this, GSK was granted an exclusive global license for the research,

Related Keywords

United States ,Japan ,Wuxi ,Jiangsu ,China ,American ,America ,Aashish Mehra ,Boehringer Ingelheim International Gmbh Germany ,Holdings Corporation Japan ,Corporation Japan ,Company Name ,Catalent Inc ,Abbvie Inc ,Thermo Fisher Scientific Inc ,Genscript Biotech Corporation ,Research Private Ltd ,Fujifilm ,Wuxi Biologics ,Wuxi Biologic ,Contract Manufacturing Market ,North America ,North American ,Sample Pages ,Market Players ,Thermo Fisher Scientific ,Samsung Biologics ,South Korea ,Boehringer Ingelheim International Gmbh ,Eurofins Scientific ,Free Customization ,Research Private ,Release Distributed ,Biotechnology Contract Manufacturing Market ,